Amy Berger, MD, PhD

Assistant Professor

I am a physician-scientist who enjoys working at the intersection of multiple areas of medicine and science. I am interested in physician-scientist training, the application of pathophysiology to clinical reasoning, and the translation of cutting edge technologies to the clinic.
Fellowship, 2017 - Academic Hospital Medicine, University of California, San Francisco
Fellowship, 2017 - Clinical and Translational Science, University of California, San Francisco
Residency, 2016 - Internal Medicine, University of California, San Francisco
MD, PhD, 2012 - PhD in Neuroscience, University of California, San Francisco
BS, 2002 - Biological Sciences, Stanford University
  1. Song E, Pincus L, Berger A, Butrymowicz A, Haemel A.. Rosai-Dorfman as a clinical mimicker of relapsing polychondritis Journal of the American Academy of Dermatology Case Reports. 2020. PMID:

  2. Berger A, Matloubian M, Shah NP, Wachter RM, DeRisi JL, Anderson M. The Molecular Medicine Investigation Unit: Linking Patient Care and Scientific Inquiry in Physician-Scientist Training. Journal of graduate medical education. 2020. PMID: 32089799

  3. Moore PC, Cortez JT, Chamberlain CE, Alba D, Berger AC, Quandt Z, Chan A, Cheng MH, Bautista JL, Peng J, German MS, Anderson MS, Oakes SA. Elastase 3B mutation links to familial pancreatitis with diabetes and pancreatic adenocarcinoma. The Journal of clinical investigation. 2019. PMID: 31369399

  4. Wilson MR, Sample HA, Zorn KC, Arevalo S, Yu G, Neuhaus J, Federman S, Stryke D, Briggs B, Langelier C, Berger A, Douglas V, Josephson SA, Chow FC, Fulton BD, DeRisi JL, Gelfand JM, Naccache SN, Bender J, Dien Bard J, Murkey J, Carlson M, Vespa PM, Vijayan T, Allyn PR, Campeau S, Humphries RM, Klausner JD, Ganzon CD, Memar F, Ocampo NA, Zimmermann LL, Cohen SH, Polage CR, DeBiasi RL, Haller B, Dallas R, Maron G, Hayden R, Messacar K, Dominguez SR, Miller S, Chiu CY. Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis. The New England journal of medicine. 2019. PMID: 31189036

  5. Berger AC, Whistler JL. Morphine-induced mu opioid receptor trafficking enhances reward yet prevents compulsive drug use. EMBO molecular medicine. 2011. PMID: 21656686

  6. Berger AC, Whistler JL. How to design an opioid drug that causes reduced tolerance and dependence. Annals of neurology. 2010. PMID: 20437553

  7. Kim JA, Bartlett S, He L, Nielsen CK, Chang AM, Kharazia V, Waldhoer M, Ou CJ, Taylor S, Ferwerda M, Cado D, Whistler JL. Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence. Current biology : CB. 2008. PMID: 18207746